EyeGene Inc.
EyeGene Inc.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Immunogenicity and Safety of Meningococcal Conjugate Vaccine (EG-MCV4) in Healthy Adults Aged 19 to 55 Years Old | Bacterial Infections and Mycoses, Infections, Neisseriaceae Infections, bacterial infectious disease, gram-negative bacterial infections, meningococcal infection | Recruiting | Phase 2 / Phase 3 | 2025-12-01 | NCT07204457 |